These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11766422)

  • 1. Applying the new cholesterol guidelines to your practice.
    Geisler SL
    JAAPA; 2001 Nov; 14(11):12-4, 17-8, 21-3. PubMed ID: 11766422
    [No Abstract]   [Full Text] [Related]  

  • 2. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 3. U.S. statin guidelines: expensive but not necessarily effective.
    Barry HC; Hoffman JR
    Am Fam Physician; 2007 May; 75(10):1453-4, 1456. PubMed ID: 17555139
    [No Abstract]   [Full Text] [Related]  

  • 4. [The new debate on cholesterol: is the lowest level the best?].
    Olsson AG
    Lakartidningen; 1999 Feb; 96(6):648-52. PubMed ID: 10087815
    [No Abstract]   [Full Text] [Related]  

  • 5. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 6. AHA and ACC outline approaches to coronary disease risk assessment.
    Morey SS
    Am Fam Physician; 2000 Apr; 61(8):2534, 2537-8, 2541-2. PubMed ID: 10794587
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
    Muntner P; Gu D; Reynolds RF; Wu X; Chen J; Whelton PK; He J
    Am J Cardiol; 2005 Nov; 96(9):1260-5. PubMed ID: 16253594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCEP's new guidelines at a glance. National Cholesterol Education Program.
    Benedict M
    Health Care Food Nutr Focus; 2002 Aug; 18(12):8-9. PubMed ID: 12192777
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers to following National Cholesterol Educational Program guidelines. An appraisal of poor physician compliance.
    Fix KN; Oberman A
    Arch Intern Med; 1992 Dec; 152(12):2385-7. PubMed ID: 1456846
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults.
    Folsom AR
    Circulation; 2003 Nov; 108(21):e152; author reply e152. PubMed ID: 14638534
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary prevention in hypercholesterolemia. High HDL cholesterol levels and female gender underestimated protective factors].
    Wahlberg G
    Lakartidningen; 2006 Jan 18-24; 103(3):131-4. PubMed ID: 16465756
    [No Abstract]   [Full Text] [Related]  

  • 13. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract]   [Full Text] [Related]  

  • 14. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prevention and treatment of hypercholesterolemia in women.
    Drown DJ
    Prog Cardiovasc Nurs; 1998; 13(3):42-3. PubMed ID: 9950023
    [No Abstract]   [Full Text] [Related]  

  • 17. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
    Lynn MM
    Adv Nurse Pract; 2000 Jun; 8(6):36-41; quiz 42-3. PubMed ID: 15658206
    [No Abstract]   [Full Text] [Related]  

  • 19. [Misleading cholesterol statistics].
    Ravnskov U
    Lakartidningen; 1999 Apr; 96(16):1947, 1949. PubMed ID: 10330861
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.